ESRP1 and breast carcinoma: Previous studies have indicated that epithelial splicing regulatory protein 1 (ESRP1) negatively regulates EMT in breast cancer, PC, oral squamous cell carcinoma, and non-small cell lung cancer [5,6,7,8].